NKGen Biotech Statistics
Total Valuation
NKGen Biotech has a market cap or net worth of 2.49 million. The enterprise value is 55.29 million.
| Market Cap | 2.49M |
| Enterprise Value | 55.29M |
Important Dates
The next estimated earnings date is Monday, December 15, 2025.
| Earnings Date | Dec 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NKGen Biotech has 124.38 million shares outstanding. The number of shares has increased by 86.88% in one year.
| Current Share Class | 124.38M |
| Shares Outstanding | 124.38M |
| Shares Change (YoY) | +86.88% |
| Shares Change (QoQ) | -3.26% |
| Owned by Insiders (%) | 20.28% |
| Owned by Institutions (%) | 2.22% |
| Float | 67.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.04 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.25 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.90 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -103.04% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 64.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.70M |
| Employee Count | 26 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NKGen Biotech has paid 53,000 in taxes.
| Income Tax | 53,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.29% in the last 52 weeks. The beta is 1.14, so NKGen Biotech's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | -94.29% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.23 |
| Relative Strength Index (RSI) | 33.14 |
| Average Volume (20 Days) | 8,901 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 87.62 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -26.97M |
| Pretax Income | -44.23M |
| Net Income | -44.29M |
| EBITDA | -25.79M |
| EBIT | -26.97M |
| Earnings Per Share (EPS) | -1.54 |
Balance Sheet
The company has 106,000 in cash and 52.91 million in debt, giving a net cash position of -52.80 million or -0.42 per share.
| Cash & Cash Equivalents | 106,000 |
| Total Debt | 52.91M |
| Net Cash | -52.80M |
| Net Cash Per Share | -0.42 |
| Equity (Book Value) | -69.91M |
| Book Value Per Share | -1.58 |
| Working Capital | -55.51M |
Cash Flow
| Operating Cash Flow | -20.88M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NKGen Biotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -86.88% |
| Shareholder Yield | -86.88% |
| Earnings Yield | -1,780.32% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |